Ascensia Diabetes Care Denmark ApS
CVR number: 36968591
Amager Strandvej 390, 2770 Kastrup
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 12 170.98 | 12 780.26 | 15 639.23 | 15 236.19 | 11 509.61 |
| Employee benefit expenses | -6 928.29 | -7 037.15 | -9 754.09 | -11 804.93 | -7 925.54 |
| Total depreciation | -2 329.72 | -2 294.65 | -2 263.76 | -2 095.41 | -1 679.40 |
| EBIT | 2 912.96 | 3 448.46 | 3 621.39 | 1 335.85 | 1 904.67 |
| Other financial income | 0.03 | ||||
| Other financial expenses | -95.73 | - 119.41 | - 133.93 | -65.34 | -76.88 |
| Pre-tax profit | 2 817.26 | 3 329.04 | 3 487.46 | 1 270.51 | 1 827.79 |
| Income taxes | - 679.67 | - 760.15 | - 806.39 | - 280.88 | - 403.96 |
| Net earnings | 2 137.59 | 2 568.89 | 2 681.07 | 989.62 | 1 423.83 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 1 463.47 | 931.30 | 399.13 | ||
| Goodwill | 9 867.96 | 9 028.13 | 8 188.30 | 7 348.48 | 6 508.65 |
| Intangible assets total | 11 331.43 | 9 959.43 | 8 587.43 | 7 348.48 | 6 508.65 |
| Land and waters | 319.71 | 586.56 | 259.21 | 296.49 | 300.81 |
| Machinery and equipment | 1 487.98 | 938.45 | 722.40 | 442.57 | 582.02 |
| Tangible assets total | 1 807.68 | 1 525.02 | 981.61 | 739.06 | 882.83 |
| Other receivables | 167.76 | 193.59 | 193.59 | 199.57 | |
| Investments total | 167.76 | 193.59 | 193.59 | 199.57 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 12 092.14 | 9 401.56 | 6 069.91 | 8 965.90 | 8 144.24 |
| Current amounts owed by group member comp. | 315.00 | ||||
| Prepayments and accrued income | 190.63 | 435.33 | 125.76 | 1 231.82 | 1 690.90 |
| Current other receivables | 72.96 | 1.47 | 1.28 | ||
| Current deferred tax assets | 188.26 | 17.54 | |||
| Short term receivables total | 12 544.00 | 9 838.36 | 6 528.21 | 10 199.00 | 9 835.15 |
| Cash and bank deposits | 7 157.47 | 9 624.41 | 13 579.78 | 3 145.17 | 8 128.24 |
| Cash and cash equivalents | 7 157.47 | 9 624.41 | 13 579.78 | 3 145.17 | 8 128.24 |
| Balance sheet total (assets) | 32 840.58 | 31 114.98 | 29 870.62 | 21 625.29 | 25 554.44 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 8 500.00 | 4 400.00 | |||
| Other reserves | -8 500.00 | -3 000.00 | |||
| Retained earnings | 11 903.79 | 14 041.38 | 16 610.27 | 10 791.34 | 7 380.96 |
| Profit of the financial year | 2 137.59 | 2 568.89 | 2 681.07 | 989.62 | 1 423.83 |
| Shareholders equity total | 14 091.38 | 16 660.27 | 19 341.34 | 11 830.96 | 10 254.79 |
| Provisions | 1 555.29 | 1 803.33 | 2 036.94 | 1 652.51 | 1 453.49 |
| Non-current leasing loans | 936.24 | 714.70 | 358.43 | 203.93 | 310.05 |
| Non-current liabilities total | 936.24 | 714.70 | 358.43 | 203.93 | 310.05 |
| Current loans from credit institutions | 878.76 | 658.63 | 539.57 | 586.18 | |
| Current trade creditors | 269.70 | 267.10 | 426.11 | 308.33 | 329.14 |
| Current owed to group member | 10 832.50 | 6 568.17 | 3 563.18 | 1 942.61 | 6 114.46 |
| Short-term deferred tax liabilities | 86.79 | 227.28 | 199.54 | ||
| Other non-interest bearing current liabilities | 5 155.48 | 4 135.85 | 3 011.18 | 4 561.71 | 3 419.54 |
| Accruals and deferred income | 474.81 | 358.38 | 2 887.26 | ||
| Current liabilities total | 16 257.67 | 11 936.68 | 8 133.92 | 7 937.88 | 13 536.12 |
| Balance sheet total (liabilities) | 32 840.58 | 31 114.98 | 29 870.62 | 21 625.29 | 25 554.44 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.